Publications by authors named "Sumithira Vasu"

Claim this Profile
F
First-line tagraxofusp induces durable responses with prolonged survival in adults younger than 50 years with blastic plasmacytoid dendritic cell neoplasm: Post hoc analysis of a phase 2 trial.
Anthony S Stein, Andrew A Lane, Kendra L Sweet, Sumithira Vasu, Alessandra Tosolini

Br J Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable post-transplant survival after first-line tagraxofusp for blastic plasmacytoid dendritic cell neoplasm.
Naveen Pemmaraju, Marina Konopleva, Muzaffar Qazilbash, Anthony S Stein, David A Rizzieri, Sumithira Vasu

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation.
Stephanie J Lee, Brent Logan, Mary M Horowitz, Jason G Dehn, Joseph Pidala, Sumithira Vasu

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial.
Jason G Dehn, Brent Logan, Stephanie J Lee, Bronwen E Shaw, Steven Devine, Sumithira Vasu

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination ruxolitinib, belumosudil, and axatilimab yields clinically significant symptomatic improvements in treatment-refractory chronic GVHD.
Jean Caputo, Ayush Peddireddi, Sarah Wall, Sumithira Vasu, Sam L Penza

Bone Marrow Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful engraftment in myeloablative transplant with cadaveric marrow after sudden unavailability of living donor.
Sumithira Vasu, Sarah A Wall, Karilyn Larkin, Sagar Munjal, Marcos J de Lima

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia.
Mark J Levis, Mehdi Hamadani, Brent R Logan, Richard J Jones, Anurag K Singh, Sumithira Vasu

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of Clonal Hematopoiesis and Cardiac Events After Allogeneic Stem Cell Transplantation.
Cooper Quartermaine, Zach Braunstein, Adnan Shaaban, Alma Habib, Onaopepo Kola-Kehinde, Sumithira Vasu

J Am Heart Assoc· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An ASTCT, CIBMTR, EBMT, and APBMT Consensus Statement Defining Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed Therapy.
Michelle L Schoettler, Eleni Gavriilaki, Enric Carreras, Cho Bo-Kyoung, Christopher E Dandoy, Sumithira Vasu

Transplant Cell Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute kidney injury after chimeric antigen receptor T-cell therapy is associated with inferior survival in patients with relapsed/refractory large B-cell lymphoma.
John Sharp, Qiuhong Zhao, Timothy J Voorhees, David A Bond, Yazeed Sawalha, Sumithira Vasu

Br J Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of first-line tagraxofusp in blastic plasmacytoid dendritic cell neoplasm with prior or concomitant hematologic malignancy: subgroup analysis of a pivotal trial.
Naveen Pemmaraju, Marina Konopleva, Kendra L Sweet, Anthony S Stein, David A Rizzieri, Sumithira Vasu

Leuk Lymphoma· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High incidence of severe TA-TMA increases mortality in adult allogeneic transplant recipients: a prospective MIDAS Consortium study.
Sumithira Vasu, Qiuhong Zhao, Elizabeth Greer Miller, Patrick Elder, Lucille Langenberg

Blood· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML.
Mark J Levis, Mehdi Hamadani, Brent R Logan, Richard J Jones, Anurag K Singh, Sumithira Vasu

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT.
Zachariah DeFilipp, Haesook T Kim, Laura W Knight, Suzanne M O'Connor, Shilton E Dhaver, Sumithira Vasu

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies.
Elvira Umyarova, Charles Pei, William Pellegrino, Qiuhong Zhao, Nidhi Sharma, Sumithira Vasu

J Hematol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination ruxolitinib and belumosudil is tolerable and induces responses despite treatment failure as monotherapies.
Jean Caputo, Ayush Peddireddi, Subodh Bhatta, Ying Huang, Evandro Bezerra, Sumithira Vasu

Leuk Lymphoma· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of chronic graft--host disease on non-relapse mortality and survival.
Justin Jiang, Audrey M Sigmund, Qiuhong Zhao, Patrick Elder, Sumithira Vasu

Leuk Lymphoma· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial.
Jason G Dehn, Brent Logan, Bronwen E Shaw, Steven Devine, Stefan O Ciurea, Sumithira Vasu

medRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma.
Nathan Denlinger, No-Joon Song, Xiaoli Zhang, Hyeongseon Jeon, Chelsea Peterson, Sumithira Vasu

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults.
Pooja Khandelwal, Lucille Langenberg, Nathan Luebbering, Kelly E Lake, Abigail Butcher, Sumithira Vasu

Blood· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia.
Bhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, Sumithira Vasu, Gregory K Behbehani

Leuk Lymphoma· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models.
Wing Keung Chan, Jessica Williams, Kinnari Sorathia, Betsy Pray, Kaled Abusaleh, Sumithira Vasu

Exp Hematol Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous graft-versus-host disease within chronic photodamaged skin: A case series demonstrating role for topical 5-fluorouracil.
Ashley N Gray, Christina Avila, Catherine G Chung, Lucia Seminario-Vidal, Alice Mims, Sumithira Vasu

JAAD Case Rep· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of diagnostic, prognostic, and risk blood and urine biomarkers of transplant-associated thrombotic microangiopathy.
Michelle L Schoettler, Harshil Bhatt, Sumithira Vasu

Front Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular therapies: Hematology and beyond.
Sumithira Vasu

Semin Hematol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis